Chang‐Hee Whang

445 citations
20 papers · 350 indexed · h-index 11
Topics
Nanoparticle-Based Drug Delivery (4 papers)RNA Interference and Gene Delivery (3 papers)Pancreatitis Pathology and Treatment (3 papers)

In The Last Decade

Chang‐Hee Whang

20 papers receiving 341 citations

Peers

Chang‐Hee Whang
Comparison fields: 5 of 90
  • Molecular Biology 113
  • Biomedical Engineering 93
  • Biomaterials 63
  • Materials Chemistry 55
  • Immunology 48
Replace Hyeongseop Keum with:
Hyeongseop Keum South Korea
Wonsik Jung South Korea
Meiyu Wu China
Cátia Domingues Portugal
Yutaka Ikeda Japan
Franceline Reynaud Brazil
Magali Zeisser Labouebe Switzerland
Qiying Shen China
Chengxin Shi China
Chang‐Hee Whang relative to Hyeongseop Keum South Korea Hyeongseop Keum's profile →
Citations per field
00.5×1.5×
Hyeongseop Keum · 1×
Citations per year

Countries citing papers authored by Chang‐Hee Whang

Since Specialization
Citations

This map shows the geographic impact of Chang‐Hee Whang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Hee Whang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Hee Whang more than expected).

Fields of papers citing papers by Chang‐Hee Whang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Hee Whang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Hee Whang. The network helps show where Chang‐Hee Whang may publish in the future.

Co-authorship network of co-authors of Chang‐Hee Whang

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Hee Whang. A scholar is included among the top collaborators of Chang‐Hee Whang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Hee Whang. Chang‐Hee Whang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 2
4 22
5 6
6 9
7 51
8 20
9 1
10 13
11 12
12 1
13 34
14 60
15 4
16 34
17 38
18 7
19 20
20 13

About Chang‐Hee Whang

Chang‐Hee Whang is a scholar working on Pharmaceutical Science, Biomaterials and Surfaces, Coatings and Films, having authored 20 papers that have together received 350 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (3 papers) and Pancreatitis Pathology and Treatment (3 papers). The work is most often cited by research in Pharmaceutical Science (41 citations), Biomaterials (63 citations) and Molecular Medicine (16 citations). Chang‐Hee Whang has collaborated with scholars based in South Korea, United States and India. Frequent co-authors include Sangyong Jon, Wonsik Jung, Hyeongseop Keum, Seongbong Jo, Jinjoo Kim, Tae Woo Kim, Dohyun Yoo, Kyeong Soo Kim, Yujin Kim and Dongin Kim. Their work appears in journals such as Advanced Materials, Angewandte Chemie International Edition and ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026